Factors Associated With Failure of HFNO in COVID-19 ICU Patients

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05798234

Acronym

CO-OHD

Enrollment

500

Registered

2023-04-04

Start date

2023-05-01

Completion date

2023-12-01

Last updated

2023-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19 Pneumonia

Brief summary

To determine the factors associated with OHD failure in COVID-19 patients admitted to an Intensive Care Unit

Detailed description

Patients admitted into 1 participating ICU for acute hypoxemic respiratory failure due to COVID-19 between 02/01/2020 and 06/01/2022 will be assessed for OHD failure

Interventions

DEVICEhigh flow oxygen device

no intervention

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients admitted in ICU for COVID-19 pneumonia

Exclusion criteria

* under immediate ECMO * secondary transferred from another ICU * readmission in the ICU * initial limitation of care

Design outcomes

Primary

Measure	Time frame	Description
High flow oxygen failure	icu stay duration	patients requiring initial high flow oxygen but finally intubated

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026